Published in J Am Coll Cardiol on November 15, 1997
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45
Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium. Eur J Nucl Med Mol Imaging (2003) 1.59
Prediction of functional recovery after revascularization using quantitative gated myocardial perfusion SPECT: a multi-center cohort study in Japan. Eur J Nucl Med Mol Imaging (2008) 1.40
Prognostic value of nitrate enhanced Tc99m MIBI SPECT study in detecting viable myocardium in patients with coronary artery disease. Int J Cardiovasc Imaging (2003) 1.40
Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ Res (2011) 1.30
Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 1.11
Myocardial contrast echocardiography for predicting functional recovery after acute myocardial infarction. Int J Cardiovasc Imaging (2002) 0.89
Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment. Br J Radiol (2011) 0.88
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
Metabolic imaging using PET. Eur J Nucl Med Mol Imaging (2007) 0.86
Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Heart (2002) 0.85
Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res (2014) 0.84
Impact of contractile reserve on acute response to cardiac resynchronization therapy. Cardiovasc Ultrasound (2008) 0.83
Defining myocardial infarction by cardiac computed tomography. Int J Cardiovasc Imaging (2008) 0.83
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2004) 0.82
Assessment of myocardial viability in patients with acute myocardial infarction by two-dimensional speckle tracking echocardiography combined with low-dose dobutamine stress echocardiography. Int J Cardiovasc Imaging (2013) 0.81
Early prediction of myocardial viability after acute myocardial infarction by two-dimensional speckle tracking imaging. J Geriatr Cardiol (2015) 0.81
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging (2005) 0.81
Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction. Eur J Nucl Med Mol Imaging (2006) 0.79
Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial). Curr Control Trials Cardiovasc Med (2004) 0.79
Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart (2000) 0.79
Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol (2015) 0.78
Transthoracic coronary flow reserve and dobutamine derived myocardial function: a 6-month evaluation after successful coronary angioplasty. Cardiovasc Ultrasound (2004) 0.77
Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling. Am J Cardiol (2009) 0.77
Detection of myocardial viability by dobutamine stress echocardiography: incremental value of diastolic wall thickness measurement. Heart (2005) 0.77
Myocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass grafting. PLoS One (2013) 0.77
The role of myocardial viability in contemporary cardiac practice. Heart Fail Rev (2017) 0.77
[Position paper on quality standards in echocardiography]. Z Kardiol (2004) 0.76
Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium. Heart (2004) 0.76
Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study. Int J Cardiovasc Imaging (2013) 0.76
Relationship between regional 18F-fluorodeoxyglucose and 13N ammonia uptake in normal myocardium assessed by positron emission tomography: patterns of mismatch and effects of aging. Int J Cardiovasc Imaging (2001) 0.75
Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium. Heart (2005) 0.75
Left ventricular remodeling after acute myocardial infarction: the influence of viability and revascularization - an echocardiographic substudy of the VIAMI-trial. Trials (2014) 0.75
Comparison of left ventricular ejection fraction values obtained using invasive contrast left ventriculography, two-dimensional echocardiography, and gated single-photon emission computed tomography. SAGE Open Med (2016) 0.75
Left ventricular electromechanical mapping: a case study of functional assessment in coronary intervention. Tex Heart Inst J (2000) 0.75
Myocardial viability assessment: poor correlation between electromechanical cardiac mapping and positron emission tomography in severe coronary artery disease. Neth Heart J (2005) 0.75
Reversible congestive heart failure caused by myocardial hibernation. Tex Heart Inst J (1999) 0.75
Dobutamine stress magnetic resonance imaging suffices for the demonstration of myocardial ischaemia and viability. Neth Heart J (2003) 0.75
Myocardial viability: strengthening the evidence base. Eur J Nucl Med Mol Imaging (2008) 0.75
Role of myocardial perfusion scintigraphy post invasive coronary angiography in patients with Myocardial Infarction. Indian J Nucl Med (2010) 0.75
The clinical use of stress echocardiography in ischemic heart disease. Cardiovasc Ultrasound (2017) 0.75
The heart failure challenge: optimizing medical and surgical management. Can J Cardiol (2006) 0.75
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against. Eur J Nucl Med Mol Imaging (2005) 0.75
Stress echocardiography: methods, indications and results. Neth Heart J (2002) 0.75
Assessment of prognosis in chronic coronary artery disease. Heart (2004) 0.75
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med (1999) 5.21
Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation (1993) 3.78
Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation (2001) 3.03
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73
Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med (1994) 2.68
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J (2004) 2.67
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation (1985) 2.61
Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol (2001) 2.57
Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation (1993) 2.32
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet (2000) 2.26
Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J (2001) 2.26
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation (1990) 2.03
Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation (2001) 2.01
Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol (1998) 1.96
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med (2001) 1.84
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation (1995) 1.81
Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73
Chronic myocardial hibernation in humans. From bedside to bench. Circulation (1997) 1.73
Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.72
Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med (2001) 1.70
Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1996) 1.70
Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol (1996) 1.66
Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol (1996) 1.63
Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation (1996) 1.62
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. Eur Heart J (2000) 1.62
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol (1999) 1.60
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol (1986) 1.57
Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J (2000) 1.55
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J (2000) 1.55
Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation (1997) 1.51
Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med (1992) 1.48
Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol (2001) 1.48
Cardiac magnetic resonance imaging findings in patients with right ventricular outflow tract premature contractions. Eur Heart J (1997) 1.48
Indications for intracoronary stent placement: the european view. Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.46
Neovascularization in human coronary atherosclerotic lesions. Cathet Cardiovasc Diagn (1996) 1.46
Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation (1984) 1.46
Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol (1999) 1.44
Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation (2001) 1.44
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation (1994) 1.44
Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med (2001) 1.44
Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation (2000) 1.43
Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study. Eur Heart J (2002) 1.42
T wave normalization during dobutamine stress testing in patients with non-Q wave myocardial infarction. A marker of myocardial ischaemia? Eur Heart J (1996) 1.42
Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol (2000) 1.42
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris. Am J Cardiol (2001) 1.42
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2001) 1.42
Flow velocity and predictors of a suboptimal coronary flow velocity reserve after coronary balloon angioplasty. Eur Heart J (2002) 1.41
The QRS score: a promising new exercise score for detecting coronary artery disease based on exercise-induced changes of Q-, R- and S-waves: a relationship with myocardial ischaemia. Eur Heart J (1996) 1.41
Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol (1999) 1.40
Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol (1996) 1.40
Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery". Eur J Vasc Endovasc Surg (2011) 1.40
Angiographic evaluation of vasomotor properties of internal mammary arteries before and after coronary artery bypass grafting in men. Am J Cardiol (1990) 1.39
Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions. Int J Card Imaging (2000) 1.39
Iodoheptadecanoic scintigraphy is not related to lipid turnover. Eur J Nucl Med (1994) 1.39
[Two patients with Eisenmenger syndrome treated with novel agents that target vasodilation of the pulmonary capillary bed]. Ned Tijdschr Geneeskd (2007) 1.38
Fractional flow reserve in patients with prior myocardial infarction. Circulation (2001) 1.37
Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol (1996) 1.36
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart (2003) 1.35
Accurate measurement of left ventricular ejection fraction by three-dimensional echocardiography. A comparison with radionuclide angiography. Circulation (1996) 1.32
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Prognostic value of exercise testing, coronary angiography and left ventriculography 6--8 weeks after myocardial infarction. Circulation (1982) 1.32
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J (2003) 1.32
Coronary artery dimensions from cineangiograms methodology and validation of a computer-assisted analysis procedure. IEEE Trans Med Imaging (1984) 1.31
Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. J Nucl Med (2001) 1.30
Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol (2001) 1.26
Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol (1992) 1.26